Table 1.
Characteristics of biopsied patients
| Characteristics | n = 63 (%) |
|---|---|
| Age (years) |
53.1 (30 to 73) |
| RFS (months) |
34.8 (4 to 190) |
| Tumor size | |
| T1 |
32 (50.8%) |
| T2 |
27 (42.9%) |
| T3 |
4 (6.3%) |
| Lymph node staging | |
| 0 |
24 (38.1%) |
| 1 |
24 (38.1%) |
| 2 |
9 (14.3%) |
| 3 |
6 (9.5%) |
| Histologic type | |
| IDC |
62 (98.4%) |
| Apocrine carcinoma |
1 (1.6%) |
| Molecule subtype | |
| Luminal |
32 (50.8%) |
| TNBC |
24 (38.1%) |
| HER2 positive |
7 (11.1%) |
| Adjuvant chemotherapy | |
| Yes |
47 (74.6%) |
| No |
16 (25.4%) |
| Adjuvant endocrine therapy | |
| Yes |
32 (50.8%) |
| No |
31 (49.2%) |
| Adjuvant radiotherapy | |
| Yes |
29 (46.0%) |
| No |
34 (54.0%) |
| Location of suspicious lesions | |
| Visceraa |
48 (76.2%) |
| Soft tissuesb |
15 (23.8%) |
| Number of suspicious lesions | |
| Single |
11 (17.5%) |
| Multiple | 52 (82.5%) |
Abbreviations: IDC, invasive ductal carcinoma, RFS, relapse free survival, TNBC, triple negative breast cancer, aViscera: liver, pleura, lung, and ovary; bSoft tissues: lymph node and soft tissue.